The regulatory effect and molecular mechanism of Epstein-Barr virus protein LMP-1 in SLE susceptibility gene expression
Immunology Letters · 2025
DOI: 10.1016/j.imlet.2025.106993 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology Letters, 2025. Verfasst von Xiang Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Ha…. Hauptthemen laut MEDLINE: Viral Matrix Proteins, Lupus Erythematosus, Systemic, Herpesvirus 4, Human, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
The development of systemic lupus erythematosus (SLE) involves both genetic and environmental factors. Epstein-Barr virus (EBV) infection has been implicated in SLE pathogenesis, particularly through the activity of latent membrane protein 1 (LMP-1). This study aimed to explore the role of LMP-1 in regulating susceptibility gene expression in SLE. Peripheral blood mononuclear cells (PBMCs) from SLE patients and H9 T cells were used to investigate this mechanism both in vivo and in vitro. RNA-seq analysis revealed that LMP-1 and the SLE susceptibility gene AT-rich interactive domain 5B (ARID5B) were significantly upregulated in SLE. Overexpression of LMP-1 in H9 T cells further increased ARID5B expression. Histone H3K27 methylation, catalyzed by enhancer of zeste homolog 2 (EZH2), was significantly elevated, suggesting epigenetic modifications play a role in this regulation. H3K27 methylation was studied due to its known involvement in transcriptional repression and chromatin remodeling in autoimmune diseases. Furthermore, phosphorylated p65 (p-p65), a marker of nuclear factor-kappa-B (NF-κB) pathway activation, was increased. Blocking the NF-κB signaling pathway reduced ARID5B expression, indicating that LMP-1 may regulate susceptibility genes through NF-κB signaling and histone modifications. These findings suggest that EBV LMP-1 contributes to SLE pathogenesis by epigenetically modulating susceptibility gene expression and activating inflammatory pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310006, Zhejiang, PR China.; Zhejiang Key Laboratory of Researc…
- Department of Nephrology, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310006, Zhejiang, PR China.
- Key Laboratory of Chinese Medicine Rheumatology of Zhejiang Province, School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310006, Zhejiang, PR China.
Zitieren
APA
Zhang, X., Hu, S., Luo, P., Li, Z., Chen, Z., Xia, C., Fan, L., Li, R., & Chen, H. (2025). The regulatory effect and molecular mechanism of Epstein-Barr virus protein LMP-1 in SLE susceptibility gene expression. Immunology Letters. https://doi.org/10.1016/j.imlet.2025.106993
Vancouver
Zhang X, Hu S, Luo P, Li Z, Chen Z, Xia C, et al. The regulatory effect and molecular mechanism of Epstein-Barr virus protein LMP-1 in SLE susceptibility gene expression. Immunology Letters. 2025. doi:10.1016/j.imlet.2025.106993
BibTeX
@article{Zhang2025,
author = {Zhang, Xiang and Hu, Shouci and Luo, Puchang and Li, Zhiyu and Chen, Zhejun and Xia, Cong and Fan, Linxuan and Li, Rongqun and Chen, Hongbo},
title = {The regulatory effect and molecular mechanism of Epstein-Barr virus protein LMP-1 in SLE susceptibility gene expression},
journal = {Immunology Letters},
year = {2025},
doi = {10.1016/j.imlet.2025.106993}
}
EUVIMED